The analysis of future developments and application potentials of CAR-T cells based on their current performance

Currently, CAR-T cell therapy has become one of the most commonly seen ways of immunotherapies to treat cancer, it is specifically targeted, with limited side effects compared with some other treatments like chemotherapy, and it has a high chance of curing the cancer with no reoccurrence. This treatment is preferred by many because of its broad application and adaptability; the T cell is gathered from the patients own system so they have no risk of rejection reaction and greatly increases the safety of the drug, excluding immune system overreaction and mortalities. This paper is to briefly introduce CAR-T cell therapy as a kind of immunotherapy: its applications for blood cancers, limitations on solid tumors, actions done to solve the treatment problems, and the potential for future applications. If the clinical trials for solid tumors succeed, the potential for safe, effective, and thorough treatment in the appliance of CAR-T cell therapy.